Significant Ownership of OPKO HEALTH, INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for OPKO HEALTH, INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Miami, FL
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
CIK context first
Continue from OPKO HEALTH, INC.
Significant Ownership of OPKO HEALTH, INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| COCP | Cocrystal Pharma, Inc. | Common Stock, par value $0.001 per share | 30% | $6,148,349 | 5,692,916 | 0% | OPKO HEALTH, INC. | 04 Nov 2026 | |
| ENTX | Entera Bio Ltd. | Ordinary Shares Nominal value of NIS 0.0000769 per share | 8.1% | $8,660,281 | 3,685,226 | OPKO HEALTH, INC. | 16 Mar 2025 |
Schedules 13D/G Reported by OPKO HEALTH, INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.